CONTACT US

WE ARE IDEOGEN

Pharma at the Speed of Life

IDEOGEN Group is a family-owned Swiss pharmaceutical group, providing global access to specialty medicines for unmet medical needs.

We specialize in the commercialization of specialty medicines in Europe with challenging and evolving healthcare dynamics. With the operational infrastructure and know-how to handle activities from un-licensed through licensed medicines; we focus on contributing to unmet needs by offering healthcare providers access to unique treatment alternatives for medical challenges patients face today.

Since 2013 we have modelled our groups activities around underserved treatment options. Solving challenging problems that have an impact on patients and prescribers’ matter to us.

We approach our partnerships with transparency, loyalty and a sense of resolve. We believe in nurturing the awareness around innovative therapies, as they meet real needs of society today.

People

88

Group Employees

80%

Pharma Background

38

Medical Field Force

Products

23

Licensed Medicines

20+

Special Access Program

80+

Healthcare Products

Places

6

Management Regions

3

Global Fulfillment Centers

35+

Countries Coverage

IDEOGEN BOARD

GROUP CEO & CHAIRMAN

H. TUYGAN GÖKER

H. Tuygan Göker is founder, CEO & Chairman of Ideogen Group GmbH. He has over 45 years of multinational pharma experience and 36 years of Senior-Level experience with F. Hoffman-La Roche, Ltd.

He served as the Pharma Operational Head and Chairman of Roche's CEMAI Region, which included 110 countries in addition to Global Strategic Director of Emerging Markets, holding a position as Member of the Pharma Operations Board. He founded numerous well-founded start-up`s, affiliates, joint ventures and partnerships in research and development, manufacturing, and commercialization platforms. Tuygan received his pharmacy degree from Gazi University in Ankara, Turkey.

GROUP COO

MEHMET C. GÖKER

With a degree in economics, MBA from Babson College and 20 Years of experience in regulated industries In US and Europe, Mehmet Goker is responsible for the finance and operations of Ideogen Group.



GROUP COO

MURAT C. GÖKER

H. Tuygan Göker is founder, CEO & Chairman of Ideogen Group GmbH. He has over 45 years of multinational pharma experience and 36 years of Senior-Level experience with F. Hoffman-La Roche, Ltd.



COMPANY MILESTONES
March
2013
IDEOGEN A.G. was founded in Basel by Tuygan Göker with the mission to incubate pharma investments and research & development.
June
2013
TrPharm joint venture launched as IDEOGEN affiliate to target commercialisation, manufacturing and R&D of specialty therapies in MENA(T) Region.
May
2014
IDEOGEN Invest into Novimmune and CEO Tuygan Göker becomes board member.
June
2014
Konsina Biopharmaceuticals launched under joint venture with Emcure Group to commercialise injectable oncology, hematology and infectious disease therapies in Turkey and Eastern Europe.
June
2016
IDEOGEN affiliate breaks ground on biologics manufacturing facility in Istanbul, Turkey as manufacturing hub for Middle East, North Africa and Turkey.
September
2017
IDEOGEN affiliate successfully completes First-in-Human Phase 1 Clinical Study for a Novel-Anti-Interleukin 1 Biologic Agent.
December
2017
IDEOGEN acquires remaining shares of Konsina from Emcure to further expand operations in Eastern Europe and MENA.
March
2018
IDEOGEN opens Ideogen LABS in Spain and Netherlands to expand R&D and operational capabilities in the EU.
August
2019
IDEOGEN A.G. initiates research program at ETH to identify multiple first-in-kind novel biomarkers for unmet medical needs related to brain diseases.
January
2020
IDEOGEN opens subsidiary in Austria for the launch of specialty therapies.
January
2021
IDEOGEN Group GmBH incorporated as headquarters for consolidation of international subsidiaries and affiliates in Switzerland.
September
2021
IDEOGEN consolidates all companies under its Ideogen Group GmBH HQ in Switzerland.
2021
Launch of BiCNU & Sidovis
December
2021
Launch of the MAP taken over from Clinigen in Europe and Turkey
August
2022
Konsina becomes IDEOGEN Turkey

COMPANY HISTORY

COMPANY HISTORY

THE OPERATIONAL EXPERIENCE

“From initial inquiry through timely delivery.”

Our portfolio focuses on medicines that require expertise in solving challenging regulatory, market access, quality and fulfillment requirements for specialized disease segments. We are a marketing and commercialization powerhouse with the experience to manage the full value-chain from unlicensed through licensed medicines.

IDEOGEN tailors its operations to therapies for unmet medical needs from early to late stage of a medicines lifecycle. This could range from small molecules, biologics, plasma derived drugs through medical devices. Our operational and commercial experience ranges from first time launches of innovative new chemical or biologic entities through to generics and improved formulations that are a geography specific need or a value-added to the healthcare ecosystem.

Our people are central to our operational success. It's the blend of our scientific expertise and the indepth understanding of the challenges ahead that ultimately gives IDEOGEN the edge in creating operational excellence.

Sterile Injectable

Cytotoxic drugs

Blood derived & plasma products

Tablets & Small Molecules

Specialty Nutritional Products

Medical Devices

-20C
Storage & Transport

2-8C
Storage & Transport

15-25C
Storage & Transport

gmp
Good Manufacturing Practice accreditation in continental Europe.
gmp
Certified with Good Distribution Practices for both registered and unlicensed medicines.
gmp
Wholesale Distribution License across multiple countries in continental Europe.
gmp
PharmacoVigilance fulfillment capabilities in-line with global guidelines.
AREAS OF SPECIALIZED NEEDS

Orphan & Rare
Disease

Unmet needs

Improved
Formulations

“Quality of Life promoters”

End of Life-Cycle
Products

“Real need no supplier
to champion the product”

Food for Special
Dietary Management

“Promoting healthier lifestyle with
dietary measures”

Supportive
Care

“Supportive therapies to relieve
side effects of treatment. “

Cost Efficient
Care

“Generics to improve cost burden
on healthcare system”

GROUP PARTNERS SERVED

*These are companies our group has had contractual agreements either through its HQ, Subsidiaries and Affiliates w/management control

HOW CAN WE HELP?

Patients Advocacy

We improve the patient experience by managing the availability of specialty therapeutics through physicians, pharmacies, and care-centers. At IDEOGEN we are committed to improving the quality of life of patients daily.
Learn more Learn less

Biotech & Pharmaceutical

Learn more

Biotech & Pharmaceutical

Success at IDEOGEN is based on a sound entrepreneurial foundation that understands the demanding commercial environment across all phases of a medicine’s life-cycle.
Success at IDEOGEN is based on a sound entrepreneurial foundation that understands the demanding commercial environment across all phases of a medicine’s life-cycle. We handle this process from pre-commercialization through post approval across multiple geographies in continental Europe.

From regulatory, quality, PharmacoVigilance and market access through unlicensed & licensed supply of therapies - IDEOGEN offers both a proven commercial and specialized scientific knowledge base, always enhancing the quality of life of patients.

Contact us to discuss your therapies access needs:

Learn more Learn less

Physicians

IDEOGEN – We define our presence by investigating medical and commercial challenges and we narrow the focus to essential decisions in catering to the needs of your patients.
Learn more
dna

Patients Advocacy

IDEOGEN is committed to improve the quality of life of patients daily. Our ability to nurture the activities of foundations, interest groups and patient associations is central in achieving our mission of improving awareness.

In order to comply with global regulations and protect patients, a medical professional should always be the only point of contact in a request for access to medication. If you are a patient, please contact your physician to discuss your treatment options.

For patient advocacy inquiries of foundations, patient associations and interest groups:
Learn more Learn less

Biotech & Pharmaceutical

Success at IDEOGEN is based on a sound entrepreneurial foundation that understands the demanding commercial environment across all phases of a medicine’s life-cycle.
Success at IDEOGEN is based on a sound entrepreneurial foundation that understands the demanding commercial environment across all phases of a medicine’s life-cycle. We handle this process from pre-commercialization through post approval across multiple geographies in continental Europe.

From regulatory, quality, PharmacoVigilance and market access through unlicensed & licensed supply of therapies - IDEOGEN offers both a proven commercial and specialized scientific knowledge base, always enhancing the quality of life of patients.

Contact us to discuss your therapies access needs:

Learn more Learn less

Physicians

IDEOGEN – a medical concierge for healthcare professionals. We define our reason d’etre by investigating medical and commercial challenges you face to narrow the focus to essential decisions in catering to the needs of your patients. From market access to indication specific queries, we streamline the quality of compliant and balanced medical information tailored to your patient’s specific needs. By listening to you, we redefine your ability to provide personalized patient care for medicines we offer under the IDEOGEN umbrella.
Learn more Learn less
SOCIAL OBLIGATION
Every aspect of our daily routine incorporates one main principle:


Adding value to society by taking decisions that have immediate impact on the overall well-being of humanity. Our processes strive to establish a win-win situation and concrete value proposition that is aligned with the needs of a global community.


CONTACT US

Get in touch

  • Medical Information
  • PharmacoVigilance
  • Customer Support
  • Partnering & Business Development